ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SSTI
SoundThinking, Inc.
SSTI has a slight edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SSTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
SSTI's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
SSTI PE Valuation
SSTI has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SSTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SSTI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over SSTI on earnings, with more consistent year-over-year improvement.
SSTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.77 | -$0.93 |
| Q2 2026 | -$1.29 | -$0.50 |
| Q1 2026 | -$1.16 | -$0.55 |
| Q4 2025 | -$0.74 | -$0.02 |
| Q3 2025 | -$0.84 | -$0.74 |
| Q2 2025 | -$0.79 | -$0.65 |
| Q1 2025 | -$0.61 | -$0.31 |
| Q4 2024 | -$0.72 | -$0.50 |
SSTI lost $1.77 per share over the past year, and its loss has widened in each of the last three quarters.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over SSTI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
SSTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25M | -0.4% |
| Q2 2026 | $23.9M | -7.7% |
| Q1 2026 | $24.2M | -15% |
| Q4 2025 | $24.8M | +5.9% |
| Q3 2025 | $25.1M | -4.4% |
| Q2 2025 | $25.9M | -4% |
| Q1 2025 | $28.3M | +12% |
| Q4 2024 | $23.4M | -10% |
SSTI's revenue is shrinking: $25M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -33% | -25 points |
| Q2 2026 | -19% | -8.1 points |
| Q1 2026 | -28% | -24 points |
| Q4 2025 | -10% | +6.1 points |
| Q3 2025 | -8.2% | -4.2 points |
| Q2 2025 | -11% | -11 points |
| Q1 2025 | -4.3% | +6 points |
| Q4 2024 | -16% | -33 points |
SSTI has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
SSTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1M | -35% |
| Q2 2026 | -$8.1M | -$5.5M |
| Q1 2026 | -$1.5M | -$474K |
| Q4 2025 | $3.7M | +$5.9M |
| Q3 2025 | $4.9M | -61% |
| Q2 2025 | -$2.7M | -194% |
| Q1 2025 | -$1M | -137% |
| Q4 2024 | -$2.2M | -$1.8M |
SSTI has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
SSTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +80.9K shares |
| 1 year | +3.3% | +427K shares |
| 3 years | +5.7% | +707K shares |
| 5 years | +13% | +1.5M shares |
| Available history | +11% | +1.3M shares |
SSTI has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $2M |
| Q2 2025 | $470,000 |
| Q1 2025 | $504,000 |
| Q4 2024 | $1,000 |
SSTI hasn't bought back shares in the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SSTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -10.3x | Net Cash |
| Q2 2025 | -4.9x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -3.5x | Net Cash |
| Q3 2024 | -1.0x | Net Cash |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | -0.2x | Net Cash |
| Q4 2023 | 0.1x | Very low |
SSTI has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
SSTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.2 | Neutral |
| Stochastic | 85.8 | Overbought |
SSTI's weekly RSI is 57 (neutral) and its Stochastic is 86 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
SSTI PE vs Technology Sector
| Metric | SSTI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
SSTI has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
SSTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.98 | 3.4% above |
| 20 week MA | $7.50 | 10% above |
| 50 week MA | $7.37 | 12% above |
| 100 week MA | $10.3 | 20% below |
| 200 week MA | $15.2 | 46% below |
SSTI has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
SSTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.3 | $38.5 | +52% |
| 2021 | $38.5 | $30.6 | -20% |
| 2022 | $30.6 | $33.3 | +8.6% |
| 2023 | $33.3 | $25.5 | -23% |
| 2024 | $25.5 | $12.8 | -50% |
| 2025 | $12.8 | $8.05 | -37% |
| 2026 YTD | $8.05 | $8.25 | +2.5% |
SSTI has the edge over ASTS on returns for 2026, with the stronger performance.